MYBL2 and neoplasm: This interaction results in increased expression of cyclin D1 and B-Myb (Myb-related protein B), promoting accelerated cell cycle progression from the G1 to S phase, along with upregulation of iNOS (inducible nitric oxide synthase), which is associated with enhanced tumor cell proliferation and metastatic capacity (Figure 1) [10].